» Articles » PMID: 7305608

The Clinical Use of Clonidine in Abrupt Withdrawal from Methadone. Effects on Blood Pressure and Specific Signs and Symptoms

Overview
Specialty Psychiatry
Date 1981 Nov 1
PMID 7305608
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Clonidine hydrochloride was found to be effective in the treatment of methadone hydrochloride withdrawal. Under controlled inpatient conditions established to assess dosage guidelines and to examine specific signs and symptoms of withdrawal, 20 of 25 (80%) patients were able to withdraw completely from methadone by the end of a two-week period. In most patients, ten to 11 days of clonidine administration, with a peak mean dose of 16 micro g /kg/day, resulted in a perceived reduction in symptoms compared with previous attempts to become opiate free. At these doses clonidine significantly reduced standing blood pressure without producing clinical problems. The withdrawal symptoms of anxiety, restlessness, insomnia, and muscular aching were most resistant to clonidine treatment and were reported by the majority of patients.

Citing Articles

Methadone Withdrawal-Induced Psychosis: A Case Report.

Oke O, Sekh M, Johnson B, Adeyemo S Cureus. 2024; 16(2):e55256.

PMID: 38558723 PMC: 10981500. DOI: 10.7759/cureus.55256.


Changes in cardiac vagal tone as measured by heart rate variability during naloxone-induced opioid withdrawal.

Levin C, Wai J, Jones J, Comer S Drug Alcohol Depend. 2019; 204:107538.

PMID: 31513980 PMC: 7017784. DOI: 10.1016/j.drugalcdep.2019.06.040.


The Black Book of Psychotropic Dosing and Monitoring.

Schatzberg A, Charles D Psychopharmacol Bull. 2018; 48(1):64-153.

PMID: 29382960 PMC: 5765435.


Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?.

Albertson T, Chenoweth J, Ford J, Owen K, Sutter M J Med Toxicol. 2014; 10(4):369-81.

PMID: 25238670 PMC: 4252292. DOI: 10.1007/s13181-014-0430-3.


The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal.

Mannelli P, Peindl K, Wu L, Patkar A, Gorelick D Am J Drug Alcohol Abuse. 2012; 38(3):200-5.

PMID: 22233189 PMC: 3578306. DOI: 10.3109/00952990.2011.644003.